NOD2-mediated Suppression of CD55 on Neutrophils Enhances C5a Generation During Polymicrobial Sepsis

PLoS Pathogens

Volumn 9, Issue 5, 2013, Pages

  Oh, Sae Jin ^a   Kim, Ji Hyung ^a,b   Chung, Doo Hyun ^a  

^a Seoul National University College of Medicine   (South Korea)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL) IMIDAZOLE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; COMPLEMENT COMPONENT C5A; DECAY ACCELERATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CELL SELECTION; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL FLUID; PHAGOCYTOSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD55; BLOTTING, WESTERN; COMPLEMENT ACTIVATION; COMPLEMENT C5A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; NOD2 SIGNALING ADAPTOR PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS;

BACTERIA (MICROORGANISMS); MUS;

EID: 84878480006     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003351     Document Type: Article

References (47)

1. Annane D, Bellissant E, Cavaillon JM, (2005) Septic shock. Lancet 365: 63-78.
2. Russell JA, (2006) Management of sepsis. N Engl J Med 355: 1699-1713.
3. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert A, et al. (1997) Sepsis and serum cytokine concentrations. Crit Care Med 25: 405-412.
4. Buras JA, Rice L, Orlow D, Pavlides S, Reenstra WR, et al. (2004) Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology 209: 629-635.
5. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, et al. (2008) Functional roles for C5a receptors in sepsis. Nat Med 14: 551-557.
6. Ward PA, (2004) The dark side of C5a in sepsis. Nat Rev Immunol 4: 133-142.
7. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A, (2005) Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 78: 325-337.
8. Zipfel PF, Skerka C, (2009) Complement regulators and inhibitory proteins. Nature reviews Immunology 9: 729-740.
9. Flierl MA, Schreiber H, Huber-Lang MS, (2006) The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome. J Invest Surg 19: 255-265.
10. Magalhaes JG, Sorbara MT, Girardin SE, Philpott DJ, (2011) What is new with Nods? Curr Opin Immunol 23: 29-34.
11. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278: 5509-5512.
12. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, et al. (2001) CARD15 mutations in Blau syndrome. Nat Genet 29: 19-20.
13. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, et al. (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105: 1195-1197.
14. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, et al. (2004) Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104: 889-894.
15. Davis KM, Nakamura S, Weiser JN, (2011) Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 121: 3666-3676.
16. Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, et al. (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 11: 55-62.
17. Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C, (2010) ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139: 1630-1641, 1641 e1631-1632.
18. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
19. Tekin D, Dalgic N, Kayaalti Z, Soylemezoglu T, Diler B, et al. (2012) Importance of NOD2/CARD15 gene variants for susceptibility to and outcome of sepsis in Turkish children. Pediatr Crit Care Med 13: e73-77.
20. Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, et al. (2007) Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110: 228-236.
21. Rehman A, Sina C, Gavrilova O, Hasler R, Ott S, et al. (2011) Nod2 is essential for temporal development of intestinal microbial communities. Gut 60: 1354-1362.
22. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, et al. (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
23. Hedl M, Abraham C, (2011) Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages. J Biol Chem 286: 26440-26449.
24. Ocuin LM, Bamboat ZM, Balachandran VP, Cavnar MJ, Obaid H, et al. (2011) Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J Leukoc Biol 89: 423-432.
25. Kasten KR, Muenzer JT, Caldwell CC, (2010) Neutrophils are significant producers of IL-10 during sepsis. Biochem Biophys Res Commun 393: 28-31.
26. Kemper C, Atkinson JP, Hourcade DE, (2010) Properdin: emerging roles of a pattern-recognition molecule. Annual review of immunology 28: 131-155.
27. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, et al. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178: 2380-2386.
28. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, et al. (2002) Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416: 190-194.
29. Windheim M, Lang C, Peggie M, Plater LA, Cohen P, (2007) Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. The Biochemical journal 404: 179-190.
30. Ferwerda G, Kramer M, de Jong D, Piccini A, Joosten LA, et al. (2008) Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta. Eur J Immunol 38: 184-191.
31. Noguchi E, Homma Y, Kang X, Netea MG, Ma X, (2009) A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol 10: 471-479.
32. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL, et al. (1992) Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. Surgery 112: 188-193; discussion 193-184.
33. McNamara MJ, Norton JA, Nauta RJ, Alexander HR, (1993) Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice. J Surg Res 54: 316-321.
34. Alexander HR, Doherty GM, Fraker DL, Block MI, Swedenborg JE, et al. (1991) Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice. J Surg Res 50: 421-424.
35. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
36. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG, (2011) The pathogenesis of sepsis. Annu Rev Pathol 6: 19-48.
37. Medof ME, Kinoshita T, Nussenzweig V, (1984) Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. The Journal of experimental medicine 160: 1558-1578.
38. Lalli PN, Strainic MG, Lin F, Medof ME, Heeger PS, (2007) Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. Journal of immunology 179: 5793-5802.
39. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, et al. (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11: R49.
40. Kumar A, Thota V, Dee L, Olson J, Uretz E, et al. (1996) Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183: 949-958.
41. Ayala A, Chung CS, Song GY, Chaudry IH, (2001) IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine 14: 37-48.
42. Kalechman Y, Gafter U, Gal R, Rushkin G, Yan D, et al. (2002) Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention. J Immunol 169: 384-392.
43. Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, et al. (2001) Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10. Infect Immun 69: 1394-1401.
44. Hotchkiss RS, Nicholson DW, (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nature reviews Immunology 6: 813-822.
45. Tigno-Aranjuez JT, Asara JM, Abbott DW, (2010) Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. Genes & development 24: 2666-2677.
46. Leslie M, (2012) Immunology. Stalling sepsis? Science 337: 1036.
47. Kim HY, Kim S, Chung DH, (2006) FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation. J Clin Invest 116: 2484-2492.